{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T19:52:32Z","timestamp":1794599552339,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"CSL Behring France"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00415-020-10041-z","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T02:29:16Z","timestamp":1594866556000},"page":"3664-3672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera"],"prefix":"10.1007","volume":"267","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5591-2774","authenticated-orcid":false,"given":"Emilien","family":"Delmont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Brodovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludivine","family":"Kouton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Allou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Brisset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Philippe","family":"Camdessanch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Cauquil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cirion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Dubard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andoni","family":"Echaniz-Laguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude-Marie","family":"Grapperon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Jauffret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Juntas-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent Daniel","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Kuntzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Labeyrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Lanfranco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Maisonobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Mavroudakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Mecharles-Darrigol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Noury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Perie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf A.","family":"Rajabally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauthier","family":"Remiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violaine","family":"Rouaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Tard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Salort-Campana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Verschueren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Viala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Attarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Boucraut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"10041_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1529-8027.2010.00278.x","volume":"15","author":"Joint Task Force of the EFNS and the PNS","year":"2010","unstructured":"Joint Task Force of the EFNS and the PNS (2010) European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripher. J Peripher Nerv Syst 15:185\u2013195","journal-title":"J Peripher Nerv Syst"},{"key":"10041_CR2","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/ana.23794","volume":"73","author":"L Querol","year":"2013","unstructured":"Querol L, Nogales-Gadea G, Rojas-Garcia R et al (2013) Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy. Ann Neurol 73:370\u2013380","journal-title":"Ann Neurol"},{"key":"10041_CR3","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","volume":"79","author":"JKM Ng","year":"2012","unstructured":"Ng JKM, Malotka J, Kawakami N et al (2012) Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology 79:2241\u20132248","journal-title":"Neurology"},{"key":"10041_CR4","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1093\/brain\/aww189","volume":"139","author":"K Doppler","year":"2016","unstructured":"Doppler K, Appeltshauser L, Villmann C et al (2016) Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy. Brain 139:2617\u20132630. https:\/\/doi.org\/10.1093\/brain\/aww189","journal-title":"Brain"},{"key":"10041_CR5","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/brain\/awx124","volume":"140","author":"E Delmont","year":"2017","unstructured":"Delmont E, Manso C, Querol L et al (2017) Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy. Brain 140:1851\u20131858. https:\/\/doi.org\/10.1093\/brain\/awx124","journal-title":"Brain"},{"key":"10041_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.nmd.2016.10.008","volume":"27","author":"J-M Vallat","year":"2017","unstructured":"Vallat J-M, Yuki N, Sekiguchi K et al (2017) Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-neurofascin 155 antibodies. Neuromuscul Disord 27:290\u2013293. https:\/\/doi.org\/10.1016\/j.nmd.2016.10.008","journal-title":"Neuromuscul Disord"},{"key":"10041_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/jnnp-2016-314895","volume":"88","author":"H Koike","year":"2017","unstructured":"Koike H, Kadoya M, Kaida K et al (2017) Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies. J Neurol Neurosurg Psychiatry 88:465\u2013473. https:\/\/doi.org\/10.1136\/jnnp-2016-314895","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10041_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww062","author":"C Manso","year":"2016","unstructured":"Manso C, Querol L, Mekaouche M et al (2016) Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects. Brain. https:\/\/doi.org\/10.1093\/brain\/aww062","journal-title":"Brain"},{"key":"10041_CR9","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1172\/JCI124694","volume":"129","author":"C Manso","year":"2019","unstructured":"Manso C, Illa I, Devaux JJ et al (2019) Anti-neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo. J Clin Invest 129:2222\u20132236","journal-title":"J Clin Invest"},{"key":"10041_CR10","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000639","author":"A Cortese","year":"2020","unstructured":"Cortese A, Lombardi R, Briani C et al (2020) Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: clinical relevance of IgG isotype. Neurol Neuroimmunol neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000000639","journal-title":"Neurol Neuroimmunol neuroinflamm"},{"key":"10041_CR11","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1093\/brain\/awv054","volume":"138","author":"Y Miura","year":"2015","unstructured":"Miura Y, Devaux JJ, Fukami Y et al (2015) Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia. Brain 138:1484\u20131491. https:\/\/doi.org\/10.1093\/brain\/awv054","journal-title":"Brain"},{"key":"10041_CR12","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/jnnp-2014-309916","volume":"86","author":"K Doppler","year":"2015","unstructured":"Doppler K, Appeltshauser L, Wilhelmi K et al (2015) Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies. J Neurol Neurosurg Psychiatry 86:720\u2013728. https:\/\/doi.org\/10.1136\/jnnp-2014-309916","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10041_CR13","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/acn3.248","volume":"2","author":"H Ogata","year":"2015","unstructured":"Ogata H, Yamasaki R, Hiwatashi A et al (2015) Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy. Ann Clin Transl Neurol 2:960\u2013971. https:\/\/doi.org\/10.1002\/acn3.248","journal-title":"Ann Clin Transl Neurol"},{"key":"10041_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jneuroim.2016.10.013","volume":"301","author":"M Kadoya","year":"2016","unstructured":"Kadoya M, Kaida K, Koike H et al (2016) IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay. J Neuroimmunol 301:16\u201322. https:\/\/doi.org\/10.1016\/j.jneuroim.2016.10.013","journal-title":"J Neuroimmunol"},{"key":"10041_CR15","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","volume":"86","author":"J Devaux","year":"2016","unstructured":"Devaux J, Yumako M, Yumako F et al (2016) Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy. Neurology 86:800\u2013807. https:\/\/doi.org\/10.1212\/WNL.0000000000002418","journal-title":"Neurology"},{"key":"10041_CR16","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1212\/WNL0000000000000205","volume":"82","author":"L Querol","year":"2014","unstructured":"Querol L, Nogales-Gadea G, Rojas-Garcia R et al (2014) Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg. Neurology 82:879\u2013886. https:\/\/doi.org\/10.1212\/WNL0000000000000205","journal-title":"Neurology"},{"key":"10041_CR17","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/mus.26010","volume":"57","author":"N Garg","year":"2017","unstructured":"Garg N, Park SB, Yiannikas C et al (2017) Neurofascin-155 IGG4 neuropathy: pathophysiological insights, spectrum of clinical severity and response to treatment. Muscle Nerve 57:848\u2013851. https:\/\/doi.org\/10.1002\/mus.26010","journal-title":"Muscle Nerve"},{"key":"10041_CR18","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1212\/WNL.0000000000004773","volume":"90","author":"E Burnor","year":"2018","unstructured":"Burnor E, Yang L, Zhou H et al (2018) Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies. Neurology 90:e31\u2013e38. https:\/\/doi.org\/10.1212\/WNL.0000000000004773","journal-title":"Neurology"},{"key":"10041_CR19","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1136\/jnnp.2005.081547","volume":"77","author":"RC Graham","year":"2006","unstructured":"Graham RC, Hughes RAC (2006) A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry 77:973\u2013976","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10041_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC van Swieten","year":"1988","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC et al (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604\u2013607","journal-title":"Stroke"},{"key":"10041_CR21","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.clinph.2020.01.013","volume":"131","author":"L Kouton","year":"2020","unstructured":"Kouton L, Boucraut J, Devaux J et al (2020) Clinical Neurophysiology Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins. Clin Neurophysiol 131:921\u2013927. https:\/\/doi.org\/10.1016\/j.clinph.2020.01.013","journal-title":"Clin Neurophysiol"},{"key":"10041_CR22","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/mdc3.12662","volume":"5","author":"C Demichelis","year":"2018","unstructured":"Demichelis C, Franciotta D, Cortese A et al (2018) Remarkable rituximab response on tremor related to acute-onset chronic inflammatory demyelinating polyradiculoneuropathy in an antineurofascin155 immunoglobulin G4-seropositive patient. Mov Disord Clin Pract 5:559\u2013560. https:\/\/doi.org\/10.1002\/mdc3.12662","journal-title":"Mov Disord Clin Pract"},{"key":"10041_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jneuroim.2019.01.017","volume":"330","author":"C Briani","year":"2019","unstructured":"Briani C, Salvalaggio A, Ruiz M et al (2019) Tongue tremor in neurofascin-155 IgG4 seropositive chronic inflammatory polyradiculoneuropathy. J Neuroimmunol 330:178\u2013180. https:\/\/doi.org\/10.1016\/j.jneuroim.2019.01.017","journal-title":"J Neuroimmunol"},{"key":"10041_CR24","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1212\/NXI.0000000000000149","volume":"2","author":"L Querol","year":"2015","unstructured":"Querol L, Rojas-Garcia R, Diaz-Manera J et al (2015) Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins. Neurol Neuroimmunol Neuroinflamm 2:e149\u2013e149. https:\/\/doi.org\/10.1212\/NXI.0000000000000149","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10041_CR25","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1002\/mus.26392","volume":"59","author":"G Taieb","year":"2018","unstructured":"Taieb G, Le Quintrec M, Pialot A et al (2018) \u201cNeuro-renal syndrome\u201d related to anti-contactin-1 antibodies. Muscle Nerve 59:E19\u2013E21. https:\/\/doi.org\/10.1002\/mus.26392","journal-title":"Muscle Nerve"},{"key":"10041_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2018.00997","volume":"9","author":"Y Hashimoto","year":"2018","unstructured":"Hashimoto Y, Ogata H, Yamasaki R et al (2018) chronic inflammatory demyelinating polyneuropathy with concurrent membranous nephropathy: an anti-paranode and podocyte protein antibody study and literature survey. Front Neurol 9:1\u201310. https:\/\/doi.org\/10.3389\/fneur.2018.00997","journal-title":"Front Neurol"},{"key":"10041_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1053\/j.ajkd.2016.01.030","volume":"68","author":"JM Francis","year":"2016","unstructured":"Francis JM, Beck LH, Salant DJ (2016) Membranous nephropathy: a journey from bench to bedside. Am J Kidney Dis 68:138\u2013147. https:\/\/doi.org\/10.1053\/j.ajkd.2016.01.030","journal-title":"Am J Kidney Dis"},{"key":"10041_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0169-328X(94)90372-7","volume":"21","author":"RA Reid","year":"1994","unstructured":"Reid RA, Bronson DD, Young KM, Hemperly JJ (1994) Identification and characterization of the human cell adhesion molecule contactin. Brain Res Mol Brain Res 21:1\u20138","journal-title":"Brain Res Mol Brain Res"},{"key":"10041_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/ki.2012.321","volume":"83","author":"L Sistani","year":"2013","unstructured":"Sistani L, Rodriguez PQ, Hultenby K et al (2013) Neuronal proteins are novel components of podocyte major processes and their expression in glomerular crescents supports their role in crescent formation. Kidney Int 83:63\u201371. https:\/\/doi.org\/10.1038\/ki.2012.321","journal-title":"Kidney Int"},{"key":"10041_CR30","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1056\/NEJMoa1109122","volume":"365","author":"O Boyer","year":"2011","unstructured":"Boyer O, Nevo F, Plaisier E et al (2011) INF2 mutations in charcot\u2013Marie\u2013Tooth disease with glomerulopathy. N Engl J Med 365:2377\u20132388. https:\/\/doi.org\/10.1056\/NEJMoa1109122","journal-title":"N Engl J Med"},{"key":"10041_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jns.2017.11.035","volume":"384","author":"A Fujita","year":"2018","unstructured":"Fujita A, Ogata H, Yamasaki R et al (2018) Parallel fluctuation of anti-neurofascin 155 antibody levels with clinico-electrophysiological findings in patients with chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Sci 384:107\u2013112. https:\/\/doi.org\/10.1016\/j.jns.2017.11.035","journal-title":"J Neurol Sci"},{"key":"10041_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-318170","author":"K Doppler","year":"2018","unstructured":"Doppler K, Stengel H, Appeltshauser L et al (2018) Neurofascin-155 IgM autoantibodies in patients with inflammatory neuropathies. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2018-318170","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10041_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/NXI.0000000000000603","volume":"6","author":"H Stengel","year":"2019","unstructured":"Stengel H, Vural A, Brunder AM et al (2019) Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy. Neurol Neuroimmunol NeuroInflamm 6:1\u201311. https:\/\/doi.org\/10.1212\/NXI.0000000000000603","journal-title":"Neurol Neuroimmunol NeuroInflamm"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10041-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-10041-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10041-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T19:53:20Z","timestamp":1626378800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-10041-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10041"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-10041-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"assertion":[{"value":"5 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study has been approved by the ethics committee of Assistance Publique des H\u00f4pitaux de Marseille (Agreement Number PADS19-365) and have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All persons involved in this study gave inform consent for participation and publication","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Data are available on demands.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}}]}}